PortfoliosLab logoPortfoliosLab logo
THNR vs. AIEQ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

THNR vs. AIEQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify AI Powered Equity ETF (AIEQ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, THNR achieves a -4.38% return, which is significantly lower than AIEQ's 9.94% return.


THNR

1D
-0.59%
1M
-1.69%
YTD
-4.38%
6M
-3.81%
1Y
7.44%
3Y*
5Y*
10Y*

AIEQ

1D
1.31%
1M
1.25%
YTD
9.94%
6M
9.90%
1Y
22.25%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. AIEQ - Yearly Performance Comparison


2026 (YTD)20252024
THNR
Amplify Weight Loss Drug & Treatment ETF
-4.38%13.65%-10.47%
AIEQ
Amplify AI Powered Equity ETF
9.94%13.96%11.31%

Correlation

The correlation between THNR and AIEQ is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.48

Correlation (All Time)
Calculated using the full available price history since May 21, 2024

0.48

THNR vs. AIEQ - Sectors Allocation Comparison


Sectors
THNR
AIEQ

Healthcare

98.8%
6.7%

Financial Services

1.1%
11.7%

Basic Materials

-

2.8%

Communication Services

-

11.2%

Consumer Cyclical

-

9.7%

Consumer Defensive

-

4.6%

Energy

-

2.8%

Industrials

-

10.4%

Real Estate

-

0.2%

Technology

-

39.7%

Utilities

-

0.3%

Healthcare

THNR
98.8%
AIEQ
6.7%

Financial Services

THNR
1.1%
AIEQ
11.7%

Basic Materials

THNR

-

AIEQ
2.8%

Communication Services

THNR

-

AIEQ
11.2%

Consumer Cyclical

THNR

-

AIEQ
9.7%

Consumer Defensive

THNR

-

AIEQ
4.6%

Energy

THNR

-

AIEQ
2.8%

Industrials

THNR

-

AIEQ
10.4%

Real Estate

THNR

-

AIEQ
0.2%

Technology

THNR

-

AIEQ
39.7%

Utilities

THNR

-

AIEQ
0.3%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

THNR vs. AIEQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR
THNR Risk / Return Rank: 1414
Overall Rank
THNR Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
THNR Sortino Ratio Rank: 1313
Sortino Ratio Rank
THNR Omega Ratio Rank: 1313
Omega Ratio Rank
THNR Calmar Ratio Rank: 1515
Calmar Ratio Rank
THNR Martin Ratio Rank: 1414
Martin Ratio Rank

AIEQ
AIEQ Risk / Return Rank: 5252
Overall Rank
AIEQ Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
AIEQ Sortino Ratio Rank: 5050
Sortino Ratio Rank
AIEQ Omega Ratio Rank: 5252
Omega Ratio Rank
AIEQ Calmar Ratio Rank: 5151
Calmar Ratio Rank
AIEQ Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. AIEQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Amplify AI Powered Equity ETF (AIEQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


THNRAIEQDifference
Sharpe ratioReturn per unit of total volatility

-1.37

Sortino ratioReturn per unit of downside risk

-1.71

Omega ratioGain probability vs. loss probability

1.08

1.31

-0.24

Calmar ratioReturn relative to maximum drawdown

0.56

2.42

-1.86

Martin ratioReturn relative to average drawdown

1.23

9.19

-7.95

THNR vs. AIEQ - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.35, which is lower than the AIEQ Sharpe Ratio of 1.72. The chart below compares the historical Sharpe Ratios of THNR and AIEQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

THNR vs. AIEQ - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than AIEQ's maximum drawdown of -24.19%. Use the drawdown chart below to compare losses from any high point for THNR and AIEQ.


Loading charts...

Drawdown Indicators


THNRAIEQDifference

Max Drawdown

Largest peak-to-trough decline

-32.51%

-24.19%

-8.32%

Max Drawdown (1Y)

Largest decline over 1 year

-12.06%

-9.11%

-2.95%

Current Drawdown

Current decline from peak

-12.25%

-1.14%

-11.11%

Average Drawdown

Average peak-to-trough decline

-12.22%

-3.28%

-8.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.44%

2.39%

+3.05%

Volatility

THNR vs. AIEQ - Volatility Comparison

Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.65% compared to Amplify AI Powered Equity ETF (AIEQ) at 4.58%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than AIEQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


THNRAIEQDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.65%

4.58%

+1.07%

Volatility (6M)

Calculated over the trailing 6-month period

13.63%

10.14%

+3.49%

Volatility (1Y)

Calculated over the trailing 1-year period

18.99%

12.79%

+6.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.34%

19.48%

-0.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.34%

19.48%

-0.14%

THNR vs. AIEQ - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is lower than AIEQ's 0.75% expense ratio.


Dividends

THNR vs. AIEQ - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.71%, more than AIEQ's 0.39% yield.


PositionTTM20252024
AIEQ
Amplify AI Powered Equity ETF
0.39%0.43%0.65%
THNR
Amplify Weight Loss Drug & Treatment ETF
1.71%1.64%0.98%

Frequently Asked Questions


THNR and AIEQ have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

THNR has higher volatility (5.65%) compared to AIEQ (4.58%). In terms of maximum drawdown, THNR dropped -32.51% vs AIEQ's -24.19%.

On 1-year performance, AIEQ leads with 22.25% vs 7.44% for THNR. On fees, THNR is cheaper at 0.59% per year. On volatility, AIEQ has been the lower-risk option at 4.58%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, AIEQ has performed better with a 22.25% return vs 7.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

THNR is cheaper with a 0.59% expense ratio, compared with 0.75% for AIEQ.

THNR has the higher dividend yield at 1.71%, compared with 0.39% for AIEQ.

THNR is categorized as Health & Biotech Equities, while AIEQ is Large Cap Growth Equities. THNR tracks VettaFi Weight Loss Drug & Treatment Index, while AIEQ tracks AI Powered Equity Index. Their fees differ too: 0.59% for THNR and 0.75% for AIEQ.

AIEQ currently has the higher Sharpe Ratio (1.72 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for THNR and AIEQ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer